ENVB
Enveric Biosciences, Inc. [ENVB] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ENVB Stock Summary
In the News
ENVB Financial details
Company Rating
-
Market Cap
7.37M
Income
-17.24M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
7
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-0.1
Forward P/E
-
PEG
0.03
P/S
-
P/B
1.13
P/C
-
P/FCF
-0.19
Quick Ratio
1.02
Current Ratio
1.39
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-8
EPS next Y
-
EPS next Q
-
EPS this Y
-37.2%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-48.05%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
12.31%
-
-
-
-
SMA20
2.24%
SMA50
-42.19%
SMA100
-48.17%
Inst Own
-
Inst Trans
-
ROA
-421%
ROE
-344%
ROC
-10.81%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.649-6.98
52W High
-
52W Low
-
RSI
36.82
Rel Volume
0.01
Avg Volume
4.5M
Volume
67.55K
Perf Week
-21.73%
Perf Month
-13.66%
Perf Quarter
-56.04%
Perf Half Y
-58.64%
-
-
-
-
Beta
0.584
-
-
Volatility
0.46%, 0.88%
Prev Close
-5.9%
Price
6.7
Change
-6.69%
Company Profile
- Volume Average 4.5M
- Market Capitalization 7.37M
- Employee 7
- CEO Dr. Joseph Edward Tucker Ph.D.
- Headquarters Naples,FL,US
- IPO Date 2015-05-04
-
Website
https://www.enveric.com 
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
